ArticleNeurosurgical review2025
Association between Braden Scale and all-cause mortality in critically ill patients with non-traumatic subarachnoid hemorrhage: analysis of the MIMIC-IV database.
Article in Neurosurgical review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Admission Braden Scale Score Is Associated with In-Hospital Mortality in ICU Patients Admitted After a Same-Level Fall: A Retrospective Cohort Study.Diagnostics (Basel, Switzerland) · 2026Article
- Association between estimated plasma volume status and all-cause mortality in critically ill patients with non-traumatic subarachnoid hemorrhage: analysis of the MIMIC-IV database.Scientific reports · 2026Article
- Braden score at ICU admission predicts 30-day mortality in acute pancreatitis.Biomolecules & biomedicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The Braden Scale (BS) is a routine nursing measure used to predict the risk of pressure ulcer events; recent studies suggest its use as a tool for identifying frailty. However, it remains unclear whether the BS holds prognostic value for patients with severe non-traumatic subarachnoid hemorrhage (SAH). In this retrospective study, participants from the Medical Information Mart for Intensive Care (MIMIC-IV) database were categorized into two groups based on their Braden Scale (BS) scores: the high-risk group (BS ≤ 15) and the low-risk group (BS > 15). The primary outcome was all-cause mortality at 3 months. A Cox proportional hazards model was constructed to examine the association between BS and all-cause mortality in critically ill patients with non-traumatic subarachnoid hemorrhage. A restricted cubic spline model was employed to assess the relationship between BS and outcomes. A total of 750 patients were included in the study, with 43% being male. The mortality rates at 1 month, 3 months, and 1 year were 21%, 25%, and 29%, respectively. Multivariable Cox proportional hazards analysis revealed that the Braden Scale (BS) was independently associated with the risk of death at 1 month (HR, 2.84 [1.26-2.81], P=0.002 ), 3 months (HR, 2.84 [1.73-4.66], P< 0.001), and 1 year (HR, 1.65 [1.15-2.38], P = 0.006). The restricted cubic spline regression model showed that the risk of death at 3 months increased linearly with decreasing BS scores. The BS is significantly associated with all-cause mortality in critically ill patients with non-traumatic SAH. This finding suggests that the BS may be useful in identifying non-traumatic SAH patients at higher risk of all-cause mortality.
Indexed as
Identifiers
40172719What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.